Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis and Evaluation
Harmange, J.C., Weiss, M.M., Germain, J., Polverino, A.J., Borg, G., Bready, J., Chen, D., Choquette, D., Coxon, A., DeMelfi, T., DiPietro, L., Doerr, N., Estrada, J., Flynn, J., Graceffa, R.F., Harriman, S.P., Kaufman, S., La, D.S., Long, A., Martin, M.W., Neervannan, S., Patel, V.F., Potashman, M., Regal, K., Roveto, P.M., Schrag, M.L., Starnes, C., Tasker, A., Teffera, Y., Wang, L., White, R.D., Whittington, D.A., Zanon, R.(2008) J Med Chem 51: 1649-1667
- PubMed: 18324761 
- DOI: https://doi.org/10.1021/jm701097z
- Primary Citation of Related Structures:  
3B8Q, 3BE2 - PubMed Abstract: 
A series of naphthyl-based compounds were synthesized as potential inhibitors of vascular endothelial growth factor (VEGF) receptors. Investigations of structure-activity relationships led to the identification of a series of naphthamides that are potent inhibitors of the VEGF receptor tyrosine kinase family ...